Historical Advances in Structural and Molecular Biology and How They Impacted Vaccine Development
Overview
Molecular Biology
Affiliations
Vaccines are among the greatest tools for prevention and control of disease. They have eliminated smallpox from the planet, decreased morbidity and mortality for major infectious diseases like polio, measles, mumps, and rubella, significantly blunted the impact of the COVID-19 pandemic, and prevented viral induced cancers such as cervical cancer caused by human papillomavirus. Recent technological advances, in genomics, structural biology, and human immunology have transformed vaccine development, enabling new technologies such as mRNA vaccines to greatly accelerate development of new and improved vaccines. In this review, we briefly highlight the history of vaccine development, and provide examples of where advances in genomics and structural biology, paved the way for development of vaccines for bacterial and viral diseases.
Design of Novel Vaccines Based on Virus-Like Particles.
Barcena J, Zamora-Ceballos M, Blanco E Subcell Biochem. 2024; 105:785-821.
PMID: 39738963 DOI: 10.1007/978-3-031-65187-8_21.
Sponholtz M, Byrne P, Lee A, Ramamohan A, Goldsmith J, McCool R Proc Natl Acad Sci U S A. 2024; 121(37):e2404250121.
PMID: 39231203 PMC: 11406251. DOI: 10.1073/pnas.2404250121.
Viral vector- and virus-like particle-based vaccines against infectious diseases: A minireview.
Henriquez R, Munoz-Barroso I Heliyon. 2024; 10(15):e34927.
PMID: 39144987 PMC: 11320483. DOI: 10.1016/j.heliyon.2024.e34927.
Mendoza-Ramirez N, Garcia-Cordero J, Shrivastava G, Cedillo-Barron L J Immunol Res. 2024; 2024:9313267.
PMID: 38939745 PMC: 11208798. DOI: 10.1155/2024/9313267.
Current Progress in Vaccines against Merkel Cell Carcinoma: A Narrative Review and Update.
Gambichler T, Schrama D, Kapynen R, Weyer-Fahlbusch S, Becker J, Susok L Vaccines (Basel). 2024; 12(5).
PMID: 38793784 PMC: 11125734. DOI: 10.3390/vaccines12050533.